CAR T cell-based therapies have revolutionized the treatment of hematological
malignancies such as leukemia and lymphoma within the last years. In contrast to the …

The risks of severe ionizing radiation exposure are increasing due to the involvement of
nuclear powers in combat operations, the increasing use of nuclear power, and the …

Mesenchymal stromal cells (MSCs) are believed to migrate to injury sites, release chemical
attractants, and either recruit local stem cells or modulate the immune system positively …

Aplastic anemia (AA) is a rare and serious disorder of hematopoietic stem cells (HSCs) that
results in the loss of blood cells due to the failure of the bone marrow (BM). Although BM …

Mesenchymal stromal cells (MSCs) are being tested as a cell therapy in clinical trials for
dozens of inflammatory disorders, with varying levels of efficacy reported. Suitable and …

Regenerative medicine is concerned with the investigation of therapeutic agents that can be
used to promote the process of regeneration after injury or in different diseases …

Acute Radiation Syndrome (ARS) is a syndrome involving damage to multiple organs
caused by exposure to a high dose of ionizing radiation over a short period of time; even low …

The pathogenesis of many age-related diseases is linked to cellular senescence, a state of
inflammation-inducing, irreversible cell cycle arrest. The consequences and mechanisms of …

In recent years, cell-based therapies have emerged as a promising approach for mitigating
radiation-induced injury. Acute radiation syndrome (ARS) results from exposure to high …

Radiation-induced skin injury (RISI) is a serious concern for nuclear accidents and cancer
radiotherapy, which seriously affects the quality of life of patients. This injury differs from …